Chemistry:BMND07

From HandWiki

BMND07, or BMND-07, is a combination of either dimethyltryptamine (DMT) or 5-MeO-DMT and another undisclosed compound which is under development for the treatment of depressive disorders.[1][2][3][4] It is being developed by Biomind Labs.[1][2] As of March 2022, it is in phase 1 clinical trials.[1][2]

See also

References